DailySand tracks biologic medicines across AI, semiconductor infrastructure, capital markets, and critical minerals supply chains. Below are curated source items and daily digests where biologic medicines appears in today's cross-sector intelligence briefing.
1 item across 1 digest
AI is being applied to accelerate drug design and development, historically one of the most expensive and failure-prone scientific endeavors with timelines spanning many years. Faster, more efficient drug discovery could reduce development costs and timelines, directly impacting pharmaceutical R&D budgets and supply chain timelines for active pharmaceutical ingredients.
Read original →
DailySand